Intended Use:
Survodutide is intended for research purposes only. Reconstitution with bacteriostatic water (BAC water) is required before use.

Storage:
Store lyophilized powder in a cool, dry place away from light. After reconstitution, keep refrigerated at 2–8°C.

Solubility:
Reconstitute with BAC water. Gently swirl to dissolve—avoid shaking.

Vial Size:
Lyophilized powder in multi-dose vial (typically supports up to 3ml reconstitution).

Shelf Life:
Lyophilized: up to 24 months
Reconstituted: recommended use within 4–6 weeks

Handling:
Maintain sterile handling procedures to ensure stability and integrity.

Dual Receptor Metabolic Studies
Preclinical research highlights Survodutide’s ability to activate both GLP-1 and glucagon receptors, resulting in combined effects on appetite suppression and increased metabolic rate.

Energy Expenditure Enhancement
Animal studies suggest that Survodutide may significantly increase energy expenditure by promoting fat oxidation through glucagon receptor pathways.

Weight Reduction Models
In metabolic disorder models, Survodutide demonstrates strong potential in reducing body weight through a dual mechanism—lower caloric intake and higher caloric burn.

Liver Fat Reduction Research
Emerging studies indicate potential benefits in reducing hepatic fat accumulation, making it of interest in liver-related metabolic research models.

Survodutide works through a dual-pathway mechanism, targeting both GLP-1 receptors and glucagon receptors:

• GLP-1 pathway
  → Reduces appetite
  → Slows gastric emptying
  → Enhances satiety signals

• Glucagon pathway
  → Increases energy expenditure
  → Promotes fat breakdown (lipolysis)
  → Enhances metabolic rate

This combination creates a “eat less + burn more” effect, which is why Survodutide is often considered a next-generation compound in metabolic research.